Invasive mould infections in newborns and children

Elio Castagnola; Maura Faraci; Francesca Fioredda; Loredana Amoroso; Francesco Risso; Alessia Franceschi; Roberto Bandettini; Gian Michele Magnano; Alessio Pini Prato; Chiara Gardella; Serena Arrigo; Marco Gattorno; Giorgio Piaggio; Antonella Ciucci; Ines Lorenzi; Anna Loy; Riccardo Haupt

doi:10.1016/j.earlhumdev.2011.01.015

Invasive mould infections in newborns and children

Early Hum Dev. 2011 Mar:87 Suppl 1:S67-9. doi: 10.1016/j.earlhumdev.2011.01.015. Epub 2011 Feb 1.

Authors

Elio Castagnola¹, Maura Faraci, Francesca Fioredda, Loredana Amoroso, Francesco Risso, Alessia Franceschi, Roberto Bandettini, Gian Michele Magnano, Alessio Pini Prato, Chiara Gardella, Serena Arrigo, Marco Gattorno, Giorgio Piaggio, Antonella Ciucci, Ines Lorenzi, Anna Loy, Riccardo Haupt

Affiliation

¹ G.Gaslini Children's Hospital, Genova, Italy. eliocastagnola@ospedale-gaslini.ge.it

PMID: 21277715
DOI: 10.1016/j.earlhumdev.2011.01.015

Abstract

Invasive mould infections represent important complications of different pediatric conditions. Epidemiology and clinical features vary according to the type of underlying conditions that determine the risk of invasive mycosis. No pediatric study has specifically evaluated the efficacy of prophylaxis or therapy invasive moulds infections, while pediatric dosages for the treatment of invasive aspergillosis are available for drugs that produced positive results in clinical trials undertaken in adults.

Publication types

Evaluation Study
Review

MeSH terms

Adult
Child*
Humans
Immunocompromised Host
Infant, Newborn
Infant, Newborn, Diseases* / epidemiology
Infant, Newborn, Diseases* / prevention & control
Infant, Newborn, Diseases* / therapy
Mycoses* / congenital
Mycoses* / epidemiology
Mycoses* / prevention & control
Mycoses* / therapy
Preventive Medicine